UROD and lung adenocarcinoma: Another closely similar CRISPR genome screening approach was employed to identify regulators of PD‐L1 expression in H358 lung adenocarcinoma; the authors identified SMAD4 and uroporphyrinogen decarboxylase (UROD) in addition to CMTM6 as novel regulators of PD‐L1 expression.122